AXIM BIOTECHNOLOGIES, INC. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Axim Biotechnologies, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Axim Biotechnologies, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $9.61K, a 50% decline year-over-year.
  • Axim Biotechnologies, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $93.9K, a 89.1% decline year-over-year.
  • Axim Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $198K, a 82.1% decline from 2022.
  • Axim Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.11M, a 3.17% decline from 2021.
  • Axim Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.14M, a 41.3% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $198K -$910K -82.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $1.11M -$36.2K -3.17% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $1.14M -$804K -41.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 $1.95M +$128K +7.02% Jan 1, 2020 Dec 31, 2020 10-K/A 2021-04-26
2019 $1.82M Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.